Target type: cellularcomponent
A chromatin silencing complex that binds and bridges separate nucleosomal histones resulting in heterochromatin assembly and chromatin looping. [GOC:bhm, GOC:dph, PMID:17540172]
The chromatin lock complex is a multi-protein complex that plays a crucial role in regulating gene expression by preventing the accessibility of DNA to transcription factors. It acts as a barrier to the progression of RNA polymerase II (RNAPII) along the DNA template, effectively halting transcription. This complex is primarily localized within the nucleus, specifically associated with the chromatin, the complex of DNA and proteins that comprises chromosomes. The core components of the chromatin lock complex include:
1. **SETD2:** A histone methyltransferase responsible for trimethylating histone H3 at lysine 36 (H3K36me3), a modification that serves as a recognition site for the complex.
2. **MLL3/MLL4:** Trithorax group proteins that catalyze the methylation of histone H3 at lysine 4 (H3K4me3), another modification crucial for gene activation.
3. **SPT6:** A histone chaperone protein that aids in the deposition of histones onto DNA, playing a role in the structural integrity of chromatin.
4. **FACT:** A complex consisting of the proteins SSRP1 and Pob1, which facilitates the passage of RNAPII through nucleosomes, a basic unit of chromatin.
5. **Mediator complex:** A large multi-protein complex that functions as a bridge between transcription factors and RNAPII, enabling the initiation of transcription.
The complex assembles at specific genomic regions, usually near gene promoters, where it forms a physical barrier that restricts the access of RNAPII to the DNA template. This blockage of RNAPII movement can prevent transcriptional elongation and thereby regulate gene expression. The chromatin lock complex is believed to play a critical role in maintaining genomic stability and controlling the proper expression of genes.'
"
Protein | Definition | Taxonomy |
---|---|---|
Lethal(3)malignant brain tumor-like protein 1 | A lethal(3)malignant brain tumor-like protein 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9Y468] | Homo sapiens (human) |
Retinoblastoma-associated protein | A retinoblastoma-associated protein that is encoded in the genome of human. [PRO:DNx, UniProtKB:P06400] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
bifemelane | bifemelane: structure given in first source | diarylmethane | |
chlorpheniramine | chlorphenamine : A tertiary amino compound that is propylamine which is substituted at position 3 by a pyridin-2-yl group and a p-chlorophenyl group and in which the hydrogens attached to the nitrogen are replaced by methyl groups. A histamine H1 antagonist, it is used to relieve the symptoms of hay fever, rhinitis, urticaria, and asthma. Chlorpheniramine: A histamine H1 antagonist used in allergic reactions, hay fever, rhinitis, urticaria, and asthma. It has also been used in veterinary applications. One of the most widely used of the classical antihistaminics, it generally causes less drowsiness and sedation than PROMETHAZINE. | monochlorobenzenes; pyridines; tertiary amino compound | anti-allergic agent; antidepressant; antipruritic drug; H1-receptor antagonist; histamine antagonist; serotonin uptake inhibitor |
maprotiline | Maprotiline: A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use. | anthracenes | |
oxybutynin | oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder. oxybutynin: RN given refers to parent cpd | acetylenic compound; carboxylic ester; racemate; tertiary alcohol; tertiary amino compound | antispasmodic drug; calcium channel blocker; local anaesthetic; muscarinic antagonist; muscle relaxant; parasympatholytic |
staurosporine | indolocarbazole alkaloid; organic heterooctacyclic compound | apoptosis inducer; bacterial metabolite; EC 2.7.11.13 (protein kinase C) inhibitor; geroprotector | |
cefsulodin | cefsulodin : A pyridinium-substituted semi-synthetic, broad-spectrum, cephalosporin antibiotic. Cefsulodin: A pyridinium-substituted semisynthetic, broad-spectrum antibacterial used especially for Pseudomonas infections in debilitated patients. | cephalosporin; organosulfonic acid; primary carboxamide | antibacterial drug |
(5-bromo-3-pyridinyl)-[4-(1-pyrrolidinyl)-1-piperidinyl]methanone | aromatic carboxylic acid; pyridinemonocarboxylic acid | ||
entecavir | benzamides; N-acylpiperidine |